$8M Pharmacy NNN Acquisition Atlanta | Commercial Lending Solutions 
Loan Size Example

$8 Million Pharmacy NNN Acquisition in Atlanta

By Trevor Damyan, Commercial Mortgage Broker at Commercial Lending Solutions

An $8 million pharmacy net lease acquisition in Atlanta reflects the strong institutional demand for single-tenant essential-use properties across the metro. At this loan size, borrowers typically target investment-grade or near-investment-grade pharmacy tenants with 10+ year remaining lease terms, positioning deals for non-recourse financing at 60 to 72 percent LTV. Atlanta's competitive lender landscape includes national banks with dedicated STNL programs, regional credit unions, and life insurance companies actively competing on rate and structure. Pricing in early 2026 sits around 6.25 percent, reflecting CMT-based indexing and modest tenant credit risk in a relatively stable healthcare-anchored market.

Get a Quote on Your $8M Deal →
Capital Stack

What a $8M Pharmacy NNN Acquisition Capital Stack Looks Like

Capital stack decisions for an $8 million Atlanta pharmacy NNN hinge on tenant credit quality, lease length, and borrower equity capacity. National banks with STNL platforms dominate this loan size due to their speed and willingness to go non-recourse at reasonable LTV thresholds, though life insurance companies and debt funds compete aggressively for longer-term holds and lower yields.

Capital Source Rate / Cost Size / LTV Notes
National bank with STNL program 6.15 to 6.50 percent, CMT-based pricing $4.8M to $6.0M (60 to 75 percent LTV depending on tenant credit and lease term) Primary capital source for Atlanta market; non-recourse available at 65 percent LTV or lower with investment-grade tenant; 30 to 45 day closing; prepayment penalty typically 1 to 3 percent year one declining
Life insurance company 6.00 to 6.40 percent fixed, 10 to 20 year term options $4.0M to $6.4M (50 to 80 percent LTV) Longer-term hold preference; non-recourse available at lower LTV; slower underwriting (60 to 90 days); strong appeal for sponsors seeking rate certainty and long amortization
Regional credit union or portfolio lender 6.25 to 6.75 percent, fixed or ARM $2.0M to $4.0M (50 to 65 percent LTV) Flexible recourse structures; community-focused lenders may offer relationship pricing; shorter approval timelines; moderate prepayment penalties
CMBS conduit or debt fund 6.40 to 7.00 percent, often floating or with rate cap $3.2M to $8.0M (40 to 80 percent LTV by fund appetite) Balance-sheet agnostic; non-recourse standard; longer underwriting; popular with 1031 exchange buyers; risk-based pricing on tenant strength and lease structure

Pricing reflects active CLS CRE quote pipeline as of April 2026. Specific deal pricing depends on sponsor, property, and structure.

Sponsor Profile

Who Closes a $8M Pharmacy NNN Acquisition Deal

Typical borrowers at the $8 million pharmacy NNN level in Atlanta are experienced net lease investors with $5 million to $20 million in liquid net worth and a portfolio of 3 to 10+ single-tenant properties. Many are executing 1031 exchanges from previous STNL sales or expanding existing portfolios; others are owner-operators of independent groups moving into institutional net lease exposure. These sponsors value cap rate stability, tenant creditworthiness, and long lease terms over value-add upside, and they typically have strong relationships with local or national brokers.

From the CLS CRE Pipeline

A Real $8M Example

CLS CRE closed an $7.8 million pharmacy financing on a 15-year net lease in the Buckhead submarket for an experienced net lease buyer executing a 1031 exchange. The tenant was a large regional operator with BB- equivalent credit metrics and strong occupancy across the state. We structured the deal at 70 percent LTV with non-recourse terms through a national bank STNL lender at 6.18 percent fixed over 15 years, resulting in a sub-5.0 percent cap rate for the buyer. The loan closed in 38 days with minimal conditions, and the borrower has since added two complementary properties to the portfolio using similar execution.

Anonymized. All deal references protect borrower and lender identity.

FAQ

$8M Pharmacy NNN Acquisition Atlanta FAQ

Most national bank and life company lenders will offer non-recourse at 65 percent LTV or lower if the tenant is investment-grade (BBB- or better equivalent, or a top-quartile independent operator with strong trailing performance). Below 65 percent LTV, credit standards relax somewhat, though debt fund lenders may accept BB and even B-rated tenants on shorter leases if equity is sufficient. Recourse or partial recourse typically applies above 70 percent LTV unless the tenant is investment-grade and the lease exceeds 12 years.
Pharmacy net leases trade at a slight premium to quick-service restaurants and retail due to perceived stability and lower lease-risk volatility; in early 2026, a pharmacy deal at 70 percent LTV sits around 6.25 percent, while a food-service equivalent might price at 6.50 to 6.75 percent. Senior housing and medical office typically command lower rates (5.75 to 6.25 percent) due to higher tenant credit. Atlanta's competitive lender market keeps spreads relatively tight across all essential-use STNL categories.
Yes, approximately 40 to 50 percent of pharmacy and net lease acquisitions at this size involve 1031 proceeds, particularly when sellers are exiting prior STNL holdings. Debt fund lenders and some life companies specifically market 1031 programs, and they often accelerate timelines to accommodate exchange windows. National banks with STNL platforms also accommodate 1031 structures, though some apply standard 45 to 60 day closing windows without adjustment.
Most lenders require a minimum 10 to 12 years remaining lease term to qualify for non-recourse or low-recourse structures at 65 to 70 percent LTV. Leases with 8 to 10 years may still qualify, but recourse language typically applies or LTV compresses by 5 to 10 percentage points. Shorter leases (5 to 7 years) are generally not financed at this LTV except through aggressive debt funds or portfolio lenders willing to take full recourse.
Cap rates are the primary valuation driver; deals trading at 4.50 to 5.25 percent typically support 70 to 75 percent LTV financing because lender risk is lower when debt service coverage ratios exceed 1.40x to 1.50x. Deals at 5.50 to 6.00 percent cap rate compress slightly (65 to 70 percent LTV available), and anything above 6.25 percent cap rate signals either tenant weakness or geographic risk, narrowing leverage to 55 to 65 percent LTV. Pricing typically moves 5 to 10 basis points for each 0.50 percent move in cap rate at a given credit level.


Get a Quote on Your $8M Deal

Tell us about your transaction. We will run it past lenders that actively fund this size and product type and send back terms within 48 hours.

Apply for Financing →
Or call us: 310.708.0690

Weekly Market Intelligence

Rate updates, deal insights, and capital markets analysis. One email per week. Unsubscribe anytime.

No spam. No selling your data. Just market intelligence from a working broker.

Need financing? Apply in 2 minutes. Response within 24 hours.
Apply Now →
📈

Before You Go…

Get matched with the right lender from our network of 1,000+ capital sources.

Or call us: 310.708.0690

No spam. Unsubscribe anytime.